Mia Levy Archives
Cancer Center investigators awarded Komen grants
Oct. 11, 2018—Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.
VICC’s Levy to lead Rush University Cancer Center
Oct. 4, 2018—Mia Levy, MD, PhD, director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Associate Professor of Cancer Research, has been named director of Rush University Cancer Center and Systems Vice President for Cancer Service at Rush University Medical Center in Chicago.
Project reveals importance of cancer gene mutation testing
Jun. 8, 2017—An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies.
VICC joins cancer genomic data sharing initiative
Jan. 19, 2017—Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine.
VICC’s Levy named Komen Scholar for breast cancer research
Jun. 2, 2016—Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar by the Susan G. Komen organization.
Precision medicine already changing cancer treatment strategies
May. 26, 2016—The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.
Levy named to new VICC informatics leadership role
Nov. 19, 2015—Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center (VICC), has been named director of Cancer Health Information and Strategy, a new management post that will expand her leadership role.
My Cancer Genome launches new mobile app
May. 29, 2014—My Cancer Genome, an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled an updated free mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations.
Agreement sets stage for enhanced My Cancer Genome
Feb. 13, 2014—Vanderbilt-Ingram Cancer Center (VICC) and GenomOncology have announced an agreement for the exclusive commercial development of a decision support tool based on My Cancer Genome, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers.
Promise of Discovery campaign adds video chat, new story lines
Oct. 21, 2011—Vanderbilt University Medical Center’s award-winning “Promise of Discovery” initiative continues with the creation of additional story lines and the launch of a new series of live online video chats. The campaign represents the promise offered by advancements in biomedical science as well as the promise held by students, faculty and staff as they strive to...
Vanderbilt: Laboratory for health care reform
Apr. 15, 2011—Vanderbilt University Medical Center is a laboratory for health care reform. Increasingly, Vanderbilt researchers are applying their expertise in informatics, genomics, drug discovery, basic science and clinical medicine to the solution of critical problems in patient care. Bedside checklists and electronic “dashboards” developed at Vanderbilt, for example, enable doctors and nurses to chart in exquisite...
Vanderbilt-Ingram Cancer Center launches online genetic research tool
Mar. 3, 2011—A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials.
